Compete for the Flemingsberg Science Award STARTUP 2024– take your ideas to the next level

Finally, registration for the Flemingsberg Science Award STARTUP 2024 is open. Do you have an exciting business idea that deserves expert testing? Are you ready to take it to the next level? Then this competition is perfect for you. Participate and compete for a prize of 10,000 SEK and three months of membership at Innovation Station – a coworking space, innovation hub, and meeting place in the heart of Campus Flemingsberg. 

“The competition is an opportunity for our students, employees, and residents of Flemingsberg to showcase their innovative ideas. Through our collaboration with Venture Cup, we aim to support and promote entrepreneurship and contribute to the development of our local ecosystem for innovation and growth in Flemingsberg,” says Johnny Högberg, CEO of Flemingsberg Science.

Flemingsberg Science AwardSTARTUP is a sub-competition of the national business plan competition Venture Cup and is aimed at students, employees, and residents of Flemingsberg. By participating in the competition, you get the chance to test your business idea with experienced industry experts. The goal of the competition is to attract innovators from Flemingsberg and help them take the step towards realizing their visions while shaping the future of companies.

Important dates:

March 11th – Last day for guaranteed feedback

March 20th – Deadline

Read more 

Sign up for the competition here

Campus Flemingsberg – A Knowledge Hub Shaping the Future Society

At Campus Flemingsberg, nearly 20,000 students study a wide range of subjects, from medical technology and healthcare, to humanities, police training, and music education. It is a place full of knowledge where the foundations of the future society are being laid, and after a pause of three years, the campus day is finally back. It's a day when students and professionals gather at Campus Flemingsberg to kick off the autumn semester together.

Sprint Bioscience in billion-kronor deal to develop new cancer drug

Sprint Bioscience has licensed its VADA cancer programme to US-based Day One Biopharmaceuticals. The deal is Sprint Bioscience’s largest to date and could be worth around SEK 3.4 billion. In the next two years, the two companies will take the steps towards clinical testing of a new cancer drug.

Go to Top